Each week, many millions are invested into life sciences startups. There are so many that often, they get lost in the weeds. We’re keeping track for you – based on regulatory filings reported to the SEC:
Bergen Medical Products – Cedar Knolls, New Jersey
- $1.7 million in equity raised of a proposed $2.1 million
- In the medical device space, but not sure what they do – just “Valued Solutions You Can Trust.”
- CEO: Robert Laudadio
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Carbylan Therapeutics – Palo Alto, California
- $5 million equity raise
- Joint pain relief
- CEO: David Renzi
Cardero Therapeutics – Sunnyvale, California
- $891,999 in equity raised of a proposed $1.5 million round
- Approaching cardiovascular and metabolic disease with a mitochondrial biogenesis approach
- CEO: George Schreiner
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Gamma Medica – Salem, New Hampshire
- $6.5 million equity raise
- Breast imaging diagnostics
- CEO: Jim Calandra
- For more info: Imaging backup for the standard mammogram meant to improve breast cancer screenings
Immunome – Wynnewood, Pennyslvania
- $467,500 in debt raised of a proposed $650,000 round
- Cancer immunotherapy
- Executive Chair: Jane H. Hollingsworth
Immunomic Therapeutics – Hershey, Pennsylvania
- $6.76 million in equity raised of a proposed $8.8 million round
- CEO: William Hearl
- Vaccines for allergy, cancer and infectious disease
K-Pax Pharmaceuticals – Mill Valley, California
- $1.46 million equity raise
- Immune modulator targeting chronic fatigue
- CEO: Jon Kaiser
Integrated Healing Technologies – Franklin, Tennessee
- $4.04 million in equity raised of a proposed $7 million round
- Wound care company
- CFO: John Blount
NextGxDx – Franklin, Tennessee
- $2.23 million equity raise
- Health IT for genetic test ordering
- CEO: Mark Harris
Parsagen Diagnostics – Andover, Massachusetts
- $3.45 million equity raise
- They’re pretty vague about what they’re up to – “Medical devices focused on women’s health”
- CEO: Ruben Salinas
VolitionRx – Singapore and Belgium
- $1.1 million equity, in two filings – $750,000 and $229,393
- Colorectal cancer diagnostics
- CEO: Cameron Reynolds
- For more info: Colorectal cancer screening could be whittled down to a drop of blood
